GET THE APP

Renalase and Dopamine study in chronic renal failure patients

Archives of Clinical Pathology.

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Renalase and Dopamine study in chronic renal failure patients

The human kidney releases a monoamine oxidase, renalase, which was observed in 2005, to the blood flow to adjust the blood stress. Renalase decreases systemic pressure by metabolizing the circulating catecholamines. Hypertension is highly customary in sufferers with diabetic nephropathy which is one of the main causes (approximately 80%) of chronic kidney disease and end-stage kidney sickness. When taken into consideration in isolation, high blood pressure and diabetes are related to an elevated risk of the development of cardiovascular and renal complications. It is identified that sympathetic nervous activation and stimulation of the renin-angiotensin-aldosterone are involved. The dopaminergic and rennin-angiotensin systems interact to regulate the blood strain. The vasodilator, Dopamine, counteracts angiotensin receptors in the paracrine regulation of renal sodium transport.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations